Copyright
©The Author(s) 2024.
World J Gastroenterol. Apr 28, 2024; 30(16): 2258-2271
Published online Apr 28, 2024. doi: 10.3748/wjg.v30.i16.2258
Published online Apr 28, 2024. doi: 10.3748/wjg.v30.i16.2258
Parameters | Scores |
Weight loss | 0: No; 1: < 10%; 2: ≥ 10% |
Stool consistency | 0: Regular; 1: Soft; 2: Diarrhea |
Blood occurrence | 0: Absence; 1: Presence |
Parameters | Score | Description |
Severity of inflammation | 0 | None |
1 | Slight | |
2 | Moderate | |
3 | Severe | |
Extent | 0 | None |
1 | Mucosa | |
2 | Mucosa and submucosa | |
3 | Transmural | |
Regeneration | 4 | No tissue repair |
3 | Surface epithelium not intact | |
2 | Regeneration with crypt depletion | |
1 | Almost complete regeneration | |
0 | Complete regeneration or normal tissue | |
Crypt damage | 0 | None |
1 | Basal 1/3 damaged | |
2 | Basal 2/3 damaged | |
3 | Only surface epithelium intact | |
4 | Entire crypt and epithelium lost | |
Involvement | 1 | 1%-25% |
2 | 26%-50% | |
3 | 51%-75% | |
4 | 76%-100% |
Human genes | Primer sequences (5’-3’) |
GAPDH | F: 5’-GAC ACC CAC TCC TCC ACC TTT-3’ |
R: 5’-TTG CTG TAG CCA AAT TCG TTG T- 3 | |
IL-1b | F: 5’-GAT GCA CCT GTA CGA TCA CT-3’ |
R: 5’-GAT GCA CCT GTA CGA TCA CT-3’ | |
IL-8 | F: 5’-AAA TCA GGA AGG CTG CCA AGA-3’ |
R: 5’-AAG GAA CCA TCT CAC TGT GTG TAA AC-3’ | |
IL-10 | F: 5’-ACTTTAAGGGTTACCTGGGTTGC-3’ |
R: 5’-TCACATGCGCCTTGATGTCTG-3’ | |
PPARa | F: 5’-CCA GTA TTT AGG AAG CTG TCC-3’ |
R: 5’-AAG TTC TTC AAG TAG CCC TCG-3’ | |
MOR | F: 5’-GAT CAT GGC CCT CTA CTC CA-3’ |
R: 5’-TGG TGG CAG TCT TCA TCT TG-3’ | |
CB2 | F: 5’-GCT AAG TGC CCT GGA GAA CGT-3’ |
R: 5’- TCA GCC CCA GCC AAG CT-3’ | |
ZO-1 | F: 5’-AGA GCA ATG GAG GAA ACA GC-3’ |
R: 5’-CCC CAC TCT GAA AAT GAG GA-3’ | |
ZO-2 | F: 5’-GGA GCT GTC AGG TTG GCT C-3’ |
R: 5’-GTC TCT GCC TCC GGA CAC T-3’ | |
Claudin2 | F: 5’-AAG GCT CTG CAA AGA ACT GC-3’ |
R: 5’-CTG CCA GGC TGA CTT CTC TC-3’ | |
MUC2 | F: 5’-CTT CGA CGG ACT CTA CTA CAG C-3’ |
R: 5’-CTT TGG TGT TGT TGC CAA AC-3’ | |
MUC5AC | F: 5’-AGAGTGGGAGCTGGGAGAGAG-3’ |
R: 5’-AGCTCA-GAGGACATATGGGAGGT-3’ |
- Citation: Valibouze C, Dubuquoy C, Chavatte P, Genin M, Maquet V, Modica S, Desreumaux P, Rousseaux C. Chitin-glucan improves important pathophysiological features of irritable bowel syndrome. World J Gastroenterol 2024; 30(16): 2258-2271
- URL: https://www.wjgnet.com/1007-9327/full/v30/i16/2258.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i16.2258